StemoniX
Latest round
- Series B
Last raised
- Feb 2019
Total raised
- $17M
Investors
- 6
About StemoniX
StemoniX, Inc.StemoniX, Inc. was founded in 2014 in Maple Grove, US, and focuses on developing cellular technologies for pharmaceutical research.StemoniX specializes in advanced cellular technologies that focus on developing innovative solutions for drug discovery and regenerative medicine. The company’s main product offerings include their proprietary organoid models and stem cell-derived tissues, which are designed to simulate human biology for research purposes. These products serve a critical function by providing a more accurate platform for pharmaceutical companies and research institutions to test drug efficacy and safety, thereby addressing the limitations of traditional animal models. Their products have been utilized in various end-use cases, including the evaluation of potential therapeutic compounds and the study of disease mechanisms.StemoniX generates revenue primarily through direct sales of their organoid models and stem cell-derived products to research institutions and pharmaceutical companies. The structure of their transactions typically involves B2B sales agreements, where clients purchase specific products to be used in their laboratory settings. Pricing plans are strategically designed to cater to the varied needs of their clientele, reflecting the complexity and specificity of the products offered. Flagship products, central to their revenue model, include proprietary organoid systems that allow researchers to conduct highly relevant studies in vitro.StemoniX is focused on expanding its product offerings with new organoid models aimed at enhancing research in personalized medicine, with expected launches in the next year. The company plans to penetrate European markets more deeply by 2022, leveraging its existing client relationships.
Who invested in StemoniX
6 investors across 2 rounds
See all investors in StemoniX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about StemoniX
Who invested in StemoniX?
StemoniX has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has StemoniX raised?
StemoniX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did StemoniX last raise money?
StemoniX's most recent round on record is a Series B, in Feb 2019.
What does StemoniX do?
StemoniX is a biotechnology company.
Where is StemoniX headquartered?
StemoniX is headquartered in Maple Grove, US.
Which VCs invest in companies like StemoniX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at StemoniX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like StemoniX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.